04.18.23 -- AI & Health Disparities: Driving A Wedge Or Closing The Gap?

The enthusiasm for the role of AI in upgrading global health and care provision is justified, provided we understand that the path to success is just as much about communication and collaborative development as it is about the raw potential of the technology itself, because realizing this technological potential requires us to consider the role of people and processes in an integrated approach.

Discover ways that leveraged machine-to-machine devices connected directly to the Internet of Things could benefit the future of clinical trials.

eSource is the bridge between the protocol and the eCRF fields. Ensure that sites are following protocol and that data are captured accurately and efficiently.

To guarantee a seamless process, organizations should consider taking the steps outlined in this article before the first patient uses a new platform.

Learn how a pharmaceutical sponsor received support for a database build of EDC and IRT and got help with data management and biostatistics.

The clinical research industry has been reluctant to adopt eConsent for several reasons. Unearth how the industry should continue exploring and implementing digital technologies in earnest in the future.

Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.

The ActiGraph Leap combines the comfort and ease of a consumer wearable with one of the most advanced and comprehensive sensor collections in the industry.

Organizations conducting clinical research can streamline the collection, processing, and submission of clinical trial data to regulatory authorities to expedite the development and approval to market.

Delve into how IQVIA eCOA captures patient data in a way that always keeps patients top of mind.

Accelerate clinical trials with unmatched control and confidence.